These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A contribution to the role of properdin in anticancer defence of the organism. Cron J. Neoplasma; 1970; 17(2):155-68. PubMed ID: 5425393 [No Abstract] [Full Text] [Related]
6. The effect of x-ray irradiation on the properdin titer of human sera. Dalos B, Bihari C, Godan F. Radiobiol Radiother (Berl); 1967; 8(2):263-9. PubMed ID: 5582347 [No Abstract] [Full Text] [Related]
7. [Interrelations of zymosan, properdin & tumors. III. Behavior of the properdin level in benzopyrene sarcoma-bearing rats treated with zymosan]. FUMAROLA D, MODICA F. Tumori; 1959; 45(1):46-53. PubMed ID: 13659609 [No Abstract] [Full Text] [Related]
8. [Influencing of the serum properdin levels of patients with neoplasms by parenteral administration of zymosan]. SZABO IK. Orv Hetil; 1960 Feb 14; 101():222-5. PubMed ID: 13836258 [No Abstract] [Full Text] [Related]
16. [Relations between properdin and tumor resistance]. Pfordte K. Z Gesamte Hyg; 1970 Jun 01; 16(6):450-8. PubMed ID: 5512283 [No Abstract] [Full Text] [Related]
19. [Microchemical method for the determination of properdin]. Pfordte K. Z Gesamte Exp Med Einschl Exp Chir; 1966 Jun 01; 140(4):294-302. PubMed ID: 5991291 [No Abstract] [Full Text] [Related]
20. [Effect of Zymosan on the properdin level of tumor patients]. NAGY S, HARTAI F. Acta Biol Med Ger; 1961 Jun 01; 6():99-102. PubMed ID: 13727492 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]